Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage

Neurocritical Care

Volumn 18, Issue 1, 2013, Pages 96-105

  Tiebosch, Ivo A C W ^a   Dijkhuizen, Rick M ^a   Cobelens, Pieter M ^b   Bouts, Mark J R J ^a   Zwartbol, René ^a   Van Der Meide, Peter H ^c   Van Den Bergh, Walter M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cerebral injury; Inflammation; Interferon ; MRI; Rats; Subarachnoid hemorrhage

Indexed keywords

BRAIN PROTEIN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; RECOMBINANT BETA INTERFERON;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG SCREENING; LEUKOCYTE ACTIVATION; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; RNA SYNTHESIS; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALITIS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84873476772     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9692-2     Document Type: Article

References (25)

1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306-18.
2. Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol. 2011;43:27-40.
3. Provencio JJ, Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol. 2005;25:435-44.
4. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73:22-41.
5. Arnason BG. Interferon beta in multiple sclerosis. Clin Immunol Immunopathol. 1996;81:1-11.
6. Kraus J, Oschmann P. The impact of interferon-beta treatment on the blood-brain barrier. Drug Discov Today. 2006;11:755-62.
7. Veldhuis WB, Derksen JW, Floris S, et al. Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab. 2003;23:1029-39.
8. Marsh B, Stevens SL, Gopalan B, et al. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for irf3. J Neurosci. 2009;29:9839-49.
9. van den Bergh WM, Schepers J, Veldhuis WB, Nicolay K, Tulleken CA, Rinkel GJ. Magnetic resonance imaging in experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 2005;147:977-83.
10. Olsson T, Kelic S, Edlund C, et al. Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur J Immunol. 1994;24:308-14.
11. Floris S, Ruuls SR, Wierinckx A, et al. Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol. 2002;127:69-79.
12. Veldhuis WB, Floris S, van der Meide PH, et al. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab. 2003;23:1060-9.
13. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 2008;167:327-34.
14. Yonemori F, Yamaguchi T, Yamada H, Tamura A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1998;18:1099-106.
15. Werner U, Szelenyi I. Measurement of mpo activity as model for detection of granulocyte infiltration in different tissues. Agents Actions 1992;Spec No:C101-C103.
16. Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J. Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation. J Surg Res. 2009;153:295-301.
17. Macleod MR, Fisher M, O'Collins V, et al. Good laboratory practice: preventing introduction of bias at the bench. Stroke. 2009;40:e50-2.
18. Lee JY, Sagher O, Keep R, Hua Y, Xi G. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery. 2009;65:331-43.
19. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40:2244-50.
20. van der Worp HB, Howells DW, Sena ES, et al. Can animal models of disease reliably inform human studies? PLoS Med. 2010;7:e1000245.
21. Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998;29:2155-61.
22. Cobelens PM, Tiebosch IA, Dijkhuizen RM, et al. Interferon-beta attenuates lung inflammation following experimental subarachnoid hemorrhage. Crit Care. 2010;14:R157.
23. Maier CM, Yu F, Nishi T, Lathrop SJ, Chan PH. Interferon-beta fails to protect in a model of transient focal stroke. Stroke. 2006;37:1116-9.
24. Tremlett H, Oger J. Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis. J Neurol. 2004;251:1297-303.
25. Dirnagl U, Lauritzen M. Fighting publication bias: introducing the negative results section. J Cereb Blood Flow Metab. 2010;30:1263-4.